Neuroprotective Research Models More recent BPC-157 research has expanded into neuroscience applications
Long-term safety beyond 12 weeks has not been formally studied in large populations
Downstream signaling involves PI3K/AKT, MAPK/ERK, and PLC- pathways, which are well-characterized drivers of synaptogenesis, dendritic spine maturation, and neuronal survival
Differences in the phosphoprotein profiles of the signaling pathway in keloid fibroblasts were detected, and the expression of p53-pS15 and FOXO4 was examined in fibroblasts and keloid tissues
The compound has never received market authorization in Canada or anywhere else, and Metabolic Pharmaceuticals terminated clinical development in 2007 after the Phase IIb obesity trial failed
Use a lower concentration product